Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 6: 32338, 2016 08 30.
Article in English | MEDLINE | ID: mdl-27573341

ABSTRACT

Natural forms of prion diseases frequently originate by oral (p.o.) infection. However, quantitative information on the gastro-intestinal (GI) absorption of prions (i.e. the bioavailability and subsequent biodistribution) is mostly unknown. The main goal of this study was to evaluate the fate of prions after oral administration, using highly purified radiolabeled PrP(Sc). The results showed a bi-phasic reduction of PrP(Sc) with time in the GI, except for the ileum and colon which showed sustained increases peaking at 3-6 hr, respectively. Plasma and whole blood (125)I-PrP(Sc) reached maximal levels by 30 min and 3 hr, respectively, and blood levels were constantly higher than plasma. Upon crossing the GI-tract (125)I-PrP(Sc) became associated to blood cells, suggesting that binding to cells decreased the biological clearance of the agent. Size-exclusion chromatography revealed that oligomeric (125)I-PrP(Sc) were transported from the intestinal tract, and protein misfolding cyclic amplification showed that PrP(Sc) in organs and blood retained the typical prion self-replicating ability. Pharmacokinetic analysis found the oral bioavailability of (125)I-PrP(Sc) to be 33.6%. Interestingly, (125)I-PrP(Sc) reached the brain in a quantity equivalent to the minimum amount needed to initiate prion disease. Our findings provide a comprehensive and quantitative study of the fate of prions upon oral infection.


Subject(s)
Biological Availability , PrPSc Proteins/genetics , Prion Diseases/genetics , Prions/genetics , Administration, Oral , Animals , Humans , Intestinal Mucosa/metabolism , Intestines/pathology , Iodine Radioisotopes/chemistry , Mice , PrPSc Proteins/metabolism , Prion Diseases/pathology , Prion Diseases/transmission , Prions/metabolism , Prions/pathogenicity , Protein Folding , Tissue Distribution/genetics
2.
J Biol Chem ; 291(24): 12880-12887, 2016 Jun 10.
Article in English | MEDLINE | ID: mdl-27056328

ABSTRACT

One intriguing feature of prion diseases is their strain variation. Prion strains are differentiated by the clinical consequences they generate in the host, their biochemical properties, and their potential to infect other animal species. The selective targeting of these agents to specific brain structures have been extensively used to characterize prion strains. However, the molecular basis dictating strain-specific neurotropism are still elusive. In this study, isolated brain structures from animals infected with four hamster prion strains (HY, DY, 139H, and SSLOW) were analyzed for their content of protease-resistant PrP(Sc) Our data show that these strains have different profiles of PrP deposition along the brain. These patterns of accumulation, which were independent of regional PrP(C) production, were not reproduced by in vitro replication when different brain regions were used as substrate for the misfolding-amplification reaction. On the contrary, our results show that in vitro replication efficiency depended exclusively on the amount of PrP(C) present in each part of the brain. Our results suggest that the variable regional distribution of PrP(Sc) in distinct strains is not determined by differences on prion formation, but on other factors or cellular pathways. Our findings may contribute to understand the molecular mechanisms of prion pathogenesis and strain diversity.


Subject(s)
Brain/metabolism , PrPSc Proteins/metabolism , Prion Diseases/metabolism , Prions/metabolism , Animals , Blotting, Western , Brain/virology , Cricetinae , Female , Host-Pathogen Interactions , Mesocricetus , PrPSc Proteins/chemistry , Prion Diseases/virology , Prions/classification , Prions/pathogenicity , Protein Folding , Species Specificity , Virulence , Virus Replication
3.
Cell Rep ; 11(8): 1168-75, 2015 May 26.
Article in English | MEDLINE | ID: mdl-25981035

ABSTRACT

Prions are the protein-based infectious agents responsible for prion diseases. Environmental prion contamination has been implicated in disease transmission. Here, we analyzed the binding and retention of infectious prion protein (PrP(Sc)) to plants. Small quantities of PrP(Sc) contained in diluted brain homogenate or in excretory materials (urine and feces) can bind to wheat grass roots and leaves. Wild-type hamsters were efficiently infected by ingestion of prion-contaminated plants. The prion-plant interaction occurs with prions from diverse origins, including chronic wasting disease. Furthermore, leaves contaminated by spraying with a prion-containing preparation retained PrP(Sc) for several weeks in the living plant. Finally, plants can uptake prions from contaminated soil and transport them to aerial parts of the plant (stem and leaves). These findings demonstrate that plants can efficiently bind infectious prions and act as carriers of infectivity, suggesting a possible role of environmental prion contamination in the horizontal transmission of the disease.


Subject(s)
Poaceae/metabolism , Prion Diseases/metabolism , Prions/metabolism , Animals , Brain/metabolism , Cricetinae , Female , Mesocricetus , Prion Diseases/transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...